Jordi Fabrega

Cofounder and CEO @ CONNECTA Therapeutics

About

Cofounder & CEO of CONNECTA Therapeutics, a biotechnology company focused on the development of new treatments for CNS unmet medical needs. Held various positions in pharmaceutical industry in Regulatory Affairs, Quality Assurance and Supply Chain areas, among others, as well as 6 years’ consultancy experience in Strategy, Management and Technology in the Pharma and Med Tech sectors. Broad experience in strategy, business development, marketing, market access and regulatory working for several international pharmaceutical companies, as well as in the biotech and medtech sector. Fully committed to boosting the value of the healthcare sector and accelerating the growth of business projects, especially in areas like internationalization of companies, guidance for entrepreneurs, technology transfer, and access to funding.

Country

Spain

City

Greater Barcelona Metropolitan Area

Industry

Pharmaceuticals

Skill

Pharmaceutical Industry, Validation, Biotechnology, Medical Devices, Pharmacy, Pharmaceutical Distribution, Strategy, Market Access, Marketing & Sales Effectiveness, Business Intelligence, Business Development, Project Management, Team Management, Regulatory Affairs

Experience

Cofounder and CEO

CONNECTA Therapeutics

2019-7 - Present · 7 yrs 3 mos

Barcelona

CONNECTA Therapeutics is a biotechnology company based in Barcelona. It is focused on the development of new treatments for CNS unmet medical needs. The company’s leading program is a small molecule with neuroplasticity modulation activity to treat Fragile X syndrome and other CNS indications.

Co-Founder

Farmàcia Sant Quirze

2017-10 - 2025-10 · 8 yrs 1 mo

Sant Quirze del Vallès

Pharmacy in Avinguda d'Ègara 83, Sant Quirze del Vallès

Director of Business Development

Biocat, BioRegion of Catalonia

2013-9 - 2017-10 · 4 yrs 2 mos

Part of the Board of Directors and responsible for the definition and progress of the cluster initiatives to develop and promote the life science sector in Catalonia. Coordinated the Spanish node of the awarded the KIC EIT Health, one of the most important health initiatives in Europe Involved in the implementation of the region RIS3 strategy in health innovation in Catalonia, alongside other stakeholders in the sector. Participated in European projects fostering the internationalization of SMEs, in entrepreneurship programs as the d•HEALTH Barcelona program (one of only four European programs in innovation in medical technology) among other programs.

Senior Manager

Antares Evidenze Health Consulting

2012-1 - 2013-9 · 1 yr 9 mos

Barcelona Area, Spain

Manager

Antares Evidenze Health Consulting

2007-10 - 2011-12 · 4 yrs 3 mos

Development of business strategies, product strategies, marketing strategies and organizational transformation strategies in Pharma/Biotech sector

Sales & Operations Planning

Eli Lilly and Company

2005 - 2005

Integrated the Sales and Operations Planning processes for the Parenteral Site. Analyzed the supply chain performance. Implemented the Operational Standards for Supply Chain Excellence (OSSCE).

Consultant

Romaco Pharma Process Solutions

2002 - 2004 · 2 yrs

Headed and provided of national and international expertise and consultation on manufacturing and quality assurance issues. Responsible for the submission and follow up of quotes and orders. Responsible for contacting customers to plan, follow-up and evaluate projects.

Consultant

SVS

2001 - 2002 · 1 yr

Prepared, supported and executed validation documentation (computerized systems, processes, equipment). Audited pharmaceutical manufacturers for GLP and GMP compliance.

Regulatory Affairs

Grifols

1999 - 2001 · 2 yrs

Prepared and filed of medicinal product submission and amendment documentation for the Health Authorities of European countries and ROW. Supported and filed of approved products documentation. Gathered in coordination with other departments (Production, Quality Assurance, Quality Control and Marketing) of the technical information needed to comply with the Health Authorities’ requirements.